Evidence map›Paper›PMID 30079560›Full record

ArticleJournal of magnetic resonance imaging : JMRI2019

Improved perfusion pattern score association with type 2 diabetes severity using machine learning pipeline: Pilot study.

Yuheng Chen, Wenna Duan, Parshant Sehrawat, Vaibhav Chauhan, Freddy J Alfaro, Anna Gavrieli, Xingye Qiao, Vera Novak, Weiying Dai

Abstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yuheng ChenDepartment of Computer Science, State University of New York at Binghamton, Binghamton, New York, USA.
Wenna DuanDepartment of Computer Science, State University of New York at Binghamton, Binghamton, New York, USA.
Parshant SehrawatDepartment of Computer Science, State University of New York at Binghamton, Binghamton, New York, USA.
Vaibhav ChauhanDepartment of Computer Science, State University of New York at Binghamton, Binghamton, New York, USA.
Freddy J AlfaroDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Anna GavrieliDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Xingye QiaoDepartment of Mathematical Sciences, State University of New York at Binghamton, Binghamton, New York, USA.
Vera NovakDepartment of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Weiying DaiDepartment of Computer Science, State University of New York at Binghamton, Binghamton, New York, USA.
Binghamton University · USBeth Israel Deaconess Medical Center · USHarvard University · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID)R01DK103902 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NOVAK, VERA · 2015 to 2019
$3.7M
Cerebromicrovascular disease in elderly with diabetesR01AG028076 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NOVAK, VERA · 2009 to 2010
$1.2M
NCATS NIH HHS UL1 TR001102NCRR NIH HHS UL1 RR025758NIA NIH HHS R01 AG028076NIDDK NIH HHS R01 DK103902
6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is associated with alterations in the blood-brain barrier, neuronal damage, and arterial stiffness, thus affecting cerebral metabolism and perfusion. There is a need to implement machine-learning methodologies to identify a T2DM-related perfusion pattern and possible relationship between the pattern and cognitive performance/disease severity. PURPOSE: To develop a machine-learning pipeline to investigate the method's discriminative value between T2DM patients and normal controls, the T2DM-related network pattern, and association of the pattern with cognitive performance/disease severity. STUDY TYPE: A cross-sectional study and prospective longitudinal study with a 2-year time interval. POPULATION: Seventy-three subjects (41 T2DM patients and 32 controls) aged 50-85 years old at baseline, and 42 subjects (19 T2DM and 23 controls) aged 53-88 years old at 2-year follow-up. FIELD STRENGTH/SEQUENCE: 3T pseudocontinuous arterial spin-labeling MRI. ASSESSMENT: Machine-learning-based pipeline (principal component analysis, feature selection, and logistic regression classifier) to generate the T2DM-related network pattern and the individual scores associated with the pattern. STATISTICAL TESTS: Linear regression analysis with gray matter volume and education years as covariates.

resultsThe machine-learning-based method is superior to the widely used univariate group comparison method with increased test accuracy, test area under the curve, test positive predictive value, adjusted McFadden's R square of 4%, 12%, 7%, and 24%, respectively. The pattern-related individual scores are associated with diabetes severity variables, mobility, and cognitive performance at baseline (P < 0.05, |r| > 0.3). More important, the longitudinal change of individual pattern scores is associated with the longitudinal change of HbA1c (P = 0.0053, r = 0.64), and baseline cholesterol (P = 0.037, r = 0.51). DATA

conclusionThe individual perfusion diabetes pattern score is a highly promising perfusion imaging biomarker for tracing the disease progression of individual T2DM patients. Further validation is needed from a larger study. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2019;49:834-844.

Indexed as

Machine LearningMagnetic Resonance ImagingAgedAged, 80 and overBrainBrain MappingCognition DisordersCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansImaging, Three-DimensionalInsulin ResistanceLinear ModelsLongitudinal StudiesMalemachine learningperfusion diabetes pattern scoretype 2 diabetes mellitus

Identifiers

PMID30079560
PMCPMC6456911
OpenAlexW2886494467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.